{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:24:21Z","timestamp":1792589061958,"version":"4.5.0"},"reference-count":55,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,11,1]]},"DOI":"10.3233\/jad-160474","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T11:06:44Z","timestamp":1474369604000},"page":"333-342","source":"Crossref","is-referenced-by-count":22,"title":["White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-\u03b2"],"prefix":"10.1177","volume":"55","author":[{"given":"Whitney M.","family":"Freeze","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands"},{"name":"Department of Radiology & Nuclear Medicine, Maastricht University Medical Center, School for Mental Health and Neuroscience, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the LeARN project","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi I. L.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed H.","family":"Gronenschild","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus F. A.","family":"Jansen","sequence":"additional","affiliation":[{"name":"Department of Radiology & Nuclear Medicine, Maastricht University Medical Center, School for Mental Health and Neuroscience, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saartje","family":"Burgmans","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Aalten","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lies","family":"Clerx","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Vos","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"van Buchem","sequence":"additional","affiliation":[{"name":"Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[{"name":"Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands"},{"name":"Institutes of Neurology and Healthcare Engineering, University College Lodon, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiesje M.","family":"van der Flier","sequence":"additional","affiliation":[{"name":"Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel M.","family":"Verbeek","sequence":"additional","affiliation":[{"name":"Departments of Neurology and Laboratory Medicine, Radboud University Medical Center Nijmegen, Donders Institute for Brain, Cognition and Behaviour, and Radboud Alzheimer Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel Olde","family":"Rikkert","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Radboud University Medical Center Nijmegen, Donders Institute for Brain, Cognition and Behaviour, and Radboud UMC, Alzheimer Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter H.","family":"Backes","sequence":"additional","affiliation":[{"name":"Department of Radiology & Nuclear Medicine, Maastricht University Medical Center, School for Mental Health and Neuroscience, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans R.","family":"Verhey","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160474_ref1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jnnp.63.6.749","article-title":"Neuropathological assessment of the lesions of significance in vascular dementia","volume":"63","author":"Esiri","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-160474_ref2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-160474_ref3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","article-title":"The overlap between vascular disease and Alzheimer\u2019s disease\u2013lessons from pathology","volume":"12","author":"Attems","year":"2014","journal-title":"BMC Med"},{"key":"10.3233\/JAD-160474_ref4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jns.2012.07.066","article-title":"Late and early onset dementia: What is the role of vascular factors? A retrospective study","volume":"322","author":"Carotenuto","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-160474_ref5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jalz.2006.09.002","article-title":"The enigma of mixed dementia","volume":"3","author":"Jellinger","year":"2007","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160474_ref6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jns.2012.07.032","article-title":"Does vascular pathology contribute to Alzheimer changes?","volume":"322","author":"Kalaria","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-160474_ref7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(04)00683-0","article-title":"Is Alzheimer\u2019s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics","volume":"3","author":"de la Torre","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-160474_ref8","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.neurobiolaging.2012.01.016","article-title":"White matter hyperintensities predict amyloid increase in Alzheimer\u2019s disease","volume":"33","author":"Grimmer","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160474_ref9","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1212\/WNL.0000000000001038","article-title":"Plasma beta-amyloid and MRI markers of cerebral small vessel disease: Three-City Dijon study","volume":"83","author":"Kaffashian","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-160474_ref10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaneurol.2014.754","article-title":"Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers","volume":"71","author":"Kester","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-160474_ref11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ana.23845","article-title":"Pathogenesis of cerebral microbleeds:imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment","volume":"73","author":"Park","year":"2013","journal-title":"Ann Neurol"},{"issue":"Suppl 3","key":"10.3233\/JAD-160474_ref12","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.3233\/JAD-132618","article-title":"Interplay between age, cerebral small vessel disease, parenchymal amyloid-beta, and tau pathology: Longitudinal studies in hypertensive stroke-prone rats","volume":"42","author":"Schreiber","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160474_ref13","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JAD-160474_ref14","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.52.7.1397","article-title":"Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment","volume":"52","author":"Jack","year":"1999","journal-title":"Neurology"},{"key":"10.3233\/JAD-160474_ref15","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.jalz.2012.11.009","article-title":"White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment","volume":"9","author":"Guzman","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160474_ref16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neurobiolaging.2014.08.009","article-title":"Hippocampal volume and shape in pure subcortical vascular dementia","volume":"36","author":"Kim","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160474_ref17","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.neurobiolaging.2014.01.005","article-title":"Comorbid Abeta toxicity and stroke: Hippocampal atrophy, pathology, and cognitive deficit","volume":"35","author":"Amtul","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160474_ref18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jamapsychiatry.2013.4506","article-title":"Synergistic effects of ischemia and beta-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment","volume":"71","author":"Lee","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.3233\/JAD-160474_ref19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neurobiolaging.2013.06.026","article-title":"Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment","volume":"35","author":"Park","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160474_ref20","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.0000000000002097","article-title":"Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia","volume":"85","author":"Ye","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-160474_ref21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/brain\/awu393","article-title":"Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly","volume":"138","author":"Vemuri","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JAD-160474_ref22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2377-12-72","article-title":"Diagnostic and economic evaluation of new biomarkers for Alzheimer\u2019s disease: The research protocol of a prospective cohort study","volume":"12","author":"Handels","year":"2012","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-160474_ref23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160474_ref24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-160474_ref25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3233\/JAD-131232","article-title":"White matter hyperintensities are positively associated with cortical thickness in Alzheimer\u2019s disease","volume":"39","author":"Jacobs","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160474_ref26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1109\/42.668698","article-title":"A nonparametric method for automatic correction of intensity nonuniformity in MRI data","volume":"17","author":"Sled","year":"1998","journal-title":"IEEE Trans Med Imaging"},{"key":"10.3233\/JAD-160474_ref27","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M","article-title":"On standardizing the MR image intensity scale","volume":"42","author":"Nyul","year":"1999","journal-title":"Magn Reson Med"},{"key":"10.3233\/JAD-160474_ref28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1474-4422(09)70013-4","article-title":"Cerebral microbleeds: A guide to detection and interpretation","volume":"8","author":"Greenberg","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-160474_ref29","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1212\/01.wnl.0000277458.26846.96","article-title":"Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment","volume":"69","author":"van de Pol","year":"2007","journal-title":"Neurology"},{"issue":"Suppl 6","key":"10.3233\/JAD-160474_ref30","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1111\/j.1528-1157.1994.tb05986.x","article-title":"MRI-based hippocampal volume measurements in epilepsy","volume":"35","author":"Jack","year":"1994","journal-title":"Epilepsia"},{"key":"10.3233\/JAD-160474_ref31","doi-asserted-by":"crossref","first-page":"e100784","DOI":"10.1371\/journal.pone.0100784","article-title":"Variability of CSF Alzheimer\u2019s disease biomarkers: Implications for clinical practice","volume":"9","author":"Vos","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160474_ref32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1373\/clinchem.2009.130518","article-title":"Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease","volume":"56","author":"Mulder","year":"2010","journal-title":"Clin Chem"},{"key":"10.3233\/JAD-160474_ref33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-160474_ref34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1017\/S1355617705050344","article-title":"Rey\u2019s verbal learning test: Normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation","volume":"11","author":"Van der Elst","year":"2005","journal-title":"J Int Neuropsychol Soc"},{"key":"10.3233\/JAD-160474_ref35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1017\/S1355617706060115","article-title":"Normative data for the Animal, Profession and Letter M Naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex","volume":"12","author":"Van der Elst","year":"2006","journal-title":"J Int Neuropsychol Soc"},{"key":"10.3233\/JAD-160474_ref36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","article-title":"Studies of interference in serial verbal reactions","volume":"18","author":"Stroop","year":"1935","journal-title":"J Exp Psychol"},{"key":"10.3233\/JAD-160474_ref37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1073191105283427","article-title":"The Stroop color-word test: Influence of age, sex, and education; and normative data for a large sample across the adult age range","volume":"13","author":"Van der Elst","year":"2006","journal-title":"Assessment"},{"key":"10.3233\/JAD-160474_ref38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Methodol"},{"key":"10.3233\/JAD-160474_ref39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/WNL.0000000000000550","article-title":"Vascular risk and Abeta interact to reduce cortical thickness in AD vulnerable brain regions","volume":"83","author":"Villeneuve","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-160474_ref40","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.neurobiolaging.2015.05.021","article-title":"Stroke risk interacts with Alzheimer\u2019s disease biomarkers on brain aging outcomes","volume":"36","author":"Hohman","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160474_ref41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.21009","article-title":"Cognitive impact of subcortical vascular and Alzheimer\u2019s disease pathology","volume":"60","author":"Chui","year":"2006","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-160474_ref42","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bbadis.2015.09.013","article-title":"The role of cerebrovascular disease when there is concomitant Alzheimer disease","volume":"1862","author":"Vemuri","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-160474_ref43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11065-014-9267-4","article-title":"The relevance of beta-amyloid on markers of Alzheimer\u2019s disease in clinically normal individuals and factors that influence these associations","volume":"24","author":"Mormino","year":"2014","journal-title":"Neuropsychol Rev"},{"key":"10.3233\/JAD-160474_ref44","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/brain\/awv007","article-title":"Amyloid-beta deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression","volume":"138","author":"Huijbers","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JAD-160474_ref45","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1212\/01.WNL.0000125337.65553.8A","article-title":"Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD","volume":"62","author":"van der Flier","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-160474_ref46","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jalz.2015.05.014","article-title":"The effect of white matterhyperintensities on neurodegeneration in mild cognitive impairment","volume":"11","author":"Tosto","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160474_ref47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.21955","article-title":"Relationship between atrophy and beta-amyloid deposition in Alzheimer disease","volume":"67","author":"Chetelat","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-160474_ref48","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awn320","article-title":"Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects","volume":"132","author":"Mormino","year":"2009","journal-title":"Brain"},{"key":"10.3233\/JAD-160474_ref49","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.12.010","article-title":"Age-related changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors","volume":"20","author":"Chowdhury","year":"2011","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.3233\/JAD-160474_ref50","doi-asserted-by":"crossref","first-page":"1006. e1025","DOI":"10.1016\/j.neurobiolaging.2011.10.001","article-title":"Cerebrovascular disease, beta-amyloid, and cognition in aging","volume":"33","author":"Marchant","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160474_ref51","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/2013.jamaneurol.405","article-title":"The aging brain and cognition: Contribution of vascular injury and abeta to mild cognitive dysfunction","volume":"70","author":"Marchant","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-160474_ref52","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/cercor\/bhr271","article-title":"CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects","volume":"22","author":"Ewers","year":"2012","journal-title":"Cereb Cortex"},{"key":"10.3233\/JAD-160474_ref53","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1212\/WNL.0b013e3182583070","article-title":"Brain atrophy accelerates cognitive decline in cerebral small vessel disease: The LADIS study","volume":"78","author":"Jokinen","year":"2012","journal-title":"Neurology"},{"key":"10.3233\/JAD-160474_ref54","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-160474_ref55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:12Z","timestamp":1777370652000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160474"}},"subtitle":[],"editor":[{"given":"Joel","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":55,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-160474","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,1]]}}}